SCHEMBL8779441

SCHEMBL8779441

CCc1ccc(C(CCOC)C2NC(=O)c3ccccc32)cc1CC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.39
HSD17B10 Q99714 2/20 0.34
DRD4 P21917 5/20 0.32
TNKS2 Q9H2K2 2/20 0.31
TNKS O95271 1/20 0.31
PARP3 Q9Y6F1 1/20 0.31
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
SLC6A3 Q01959 1/20 0.31
ALDH1A1 P00352 1/20 0.30
HPGD P15428 1/20 0.30
KDM4E B2RXH2 1/20 0.30
NPC1 O15118 1/20 0.30
KMT2A Q03164 1/20 0.30
DRD2 P14416 3/20 0.30
DRD3 P35462 1/20 0.30
HTR2A P28223 1/20 0.30
HTR2C P28335 1/20 0.30
HTR2B P41595 1/20 0.30
PARP1 P09874 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8779431 0.86 CYP1A2 (0.40) CYP1A2HSD17B10DRD4TNKS2TNKS
SCHEMBL8420151 0.78 TNF (0.43) CYP1A2ALDH1A1HPGDKDM4E
SCHEMBL8779393 0.78 CYP1A2 (0.37) CYP1A2HSD17B10TNKS2TNKSPARP3
SCHEMBL8779469 0.76 TNF (0.42) CYP1A2ALDH1A1HPGDKDM4E
SCHEMBL8419507 0.76 KDM4E (0.44) ALDH1A1HPGDKDM4E
SCHEMBL8421376 0.74 TNF (0.56) HSD17B10ALDH1A1HPGDKDM4E
SCHEMBL8421923 0.74 TNF (0.56) HSD17B10ALDH1A1HPGDKDM4E
SCHEMBL8779459 0.73 TNF (0.45) CYP1A2HSD17B10ALDH1A1HPGDKDM4E
SCHEMBL7439026 0.72 TNF (0.53)
SCHEMBL8779410 0.71 TNF (0.49) HSD17B10ALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0797437-A1 IMMUNOTHERAPEUTIC IMIDES/AMIDES AND THEIR USE FOR REDUCING LEVELS OF TNF$g(a) CELGENE CORPORATION (US) 1997-10-01 EP disclosed
WO-1996020705-A1 IMMUNOTHERAPEUTIC IMIDES/AMIDES AND THEIR USE FOR REDUCING LEVELS OF TNF$g(a) CELGENE CORPORATION (US) 1996-07-11 WO disclosed